Industry / Canada
Apotex Expands In Europe
November 2007 | FDI AlertLeading Canadian generics firm Apotex has acquired Belgian drugmaker Topgen for an undisclosed fee. In doing so, the North American company will increase its footprint in Europe, whilst gaining a launching pad in the EU for many of its products currently in development.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
